One of the CEPHALOSPORINS that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
Cefotiam has been studied across 13 research domains including 🫘 Kidney, 😴 Sleep, 🔬 Oncology, 🧠 Focus & Attention, 🫁 Respiratory. The primary research focus is 🫘 Kidney with 7% of studies addressing this area.
This evidence profile for Cefotiam is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.